Condition: Prosthetic Valve Endocarditis · Sponsor: Assistance Publique - Hôpitaux de Paris
In patients with prosthetic valve endocarditis (PVE) and pathological valvular FDG uptake on the initial FDG-PET and not referred to valve replacement at the acute phase, the study will assess whether FDG-PET is able to identify those at increased risk of PVE relapse.
This description comes directly from the study's public registry record.
François Rouzet, MD, PHD · 01.40.25.64.11 · francois.rouzet@aphp.fr
Xavier Duval, MD, PHD · xavier.duval@aphp.fr
Always discuss trial participation with your own doctor first.
| Hôpital Bichat-Claude Bernard | Paris, France, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05989152